(Table 3) As with enfortumab vedotin, the 3 cases of brentuximab vedotin–associated DKA were associated with severe insulin resistance, with insulin requirements up to 10 725 units per day in one case [18]. The gene discussed is INS; the disease is Insulin resistance.